MISCELLANEOUS :: LONZA EXTENDS PARTNERSHIP WITH PHARMACYCLICS TO SUPPORT MANUFACTURING OF RECENTLY APPROVED ONCOLOGY THERAPEUTIC, IMBRUVICA

* Asterisks denote mandatory information

Name of Announcer *
LONZA GROUP LTD
Company Registration No.
CH-020.3.021.634-0
Announcement submitted on behalf of
LONZA GROUP LTD
Announcement is submitted with respect to *
LONZA GROUP LTD
Announcement is submitted by *
Esther Au
Designation *
SGXNET Authorised User
Date & Time of Broadcast
13-Jan-2014 14:31:15
Announcement No.
00025

ANNOUNCEMENT DETAILS

Announcement Title *
Lonza Extends Partnership with Pharmacyclics to Support Manufacturing of Recently Approved Oncology Therapeutic, IMBRUVICA
Description
Please see attached
Attachments
140113_Pharmacyclics_e_final.pdf
Total size =28K
(2048K size limit recommended)